Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of AQP9 mRNA | decreases expression | 18648102
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of AQP9 protein | affects expression | 20106945
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of AQP9 mRNA | increases expression | 17026757
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of AQP9 protein | increases expression | 17026757
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AQP9 mRNA | affects expression | 16483693
|
D015113 |
Androstane-3,17-diol |
Androstane-3,17-diol results in increased expression of AQP9 mRNA | increases expression | 17026757
|
D015113 |
Androstane-3,17-diol |
Androstane-3,17-diol results in increased expression of AQP9 protein | increases expression | 17026757
|
D000965 |
Antimony |
AQP9 protein results in increased uptake of and results in increased susceptibility to Antimony | increases response to substance|increases uptake | 15336539
|
C006632 |
arsenic trioxide |
AQP9 protein results in increased import of arsenic trioxide | increases import | 16968895
|
C006632 |
arsenic trioxide |
AQP9 protein results in increased susceptibility to arsenic trioxide | increases response to substance | 16968895
|
C006632 |
arsenic trioxide |
AQP9 protein results in increased uptake of and results in increased susceptibility to arsenic trioxide | increases response to substance|increases uptake | 15336539
|
C006632 |
arsenic trioxide |
AQP9 protein results in increased uptake of arsenic trioxide | increases uptake | 19100828
|
C006632 |
arsenic trioxide |
arsenic trioxide affects the expression of AQP9 protein | affects expression | 19100828
|
C006632 |
arsenic trioxide |
[Tretinoin co-treated with arsenic trioxide] results in increased expression of AQP9 mRNA | affects cotreatment|increases expression | 19225113
|
C006632 |
arsenic trioxide |
[Tretinoin results in increased expression of AQP9 mRNA] which results in increased import of arsenic trioxide | increases expression|increases import | 16968895
|
C006632 |
arsenic trioxide |
[Tretinoin results in increased expression of AQP9 mRNA] which results in increased susceptibility to arsenic trioxide | increases expression|increases response to substance | 16968895
|
C015001 |
arsenite |
AQP9 protein results in increased susceptibility to arsenite | increases response to substance | 19341753
|
C015001 |
arsenite |
AQP9 protein results in increased uptake of arsenite | increases uptake | 19341753
|
C015001 |
arsenite |
Sorbitol inhibits the reaction [AQP9 protein results in increased uptake of arsenite] | decreases reaction|increases uptake | 19341753
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of AQP9 mRNA | decreases expression | 20064835
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of AQP9 mRNA | increases expression | 16644059
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of AQP9 mRNA | decreases expression | 20106945
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of AQP9 mRNA | affects cotreatment|increases expression | 18313992
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of AQP9 mRNA | decreases expression | 19638242
|
D004958 |
Estradiol |
Estradiol results in increased expression of AQP9 mRNA | increases expression | 17026757
|
D004958 |
Estradiol |
Estradiol results in increased expression of AQP9 protein | increases expression | 17026757
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of AQP9 mRNA | increases expression | 17108234
|
C027185 |
indirubin |
[indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | affects cotreatment|increases expression|increases reaction | 18344322
|
C027185 |
indirubin |
indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA] | increases expression|increases reaction | 18344322
|
C027185 |
indirubin |
indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | increases expression|increases reaction | 18344322
|
C027185 |
indirubin |
[[tetraarsenic tetrasulfide co-treated with indirubin] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C027185 |
indirubin |
[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein | affects cotreatment|increases expression | 18344322
|
C027185 |
indirubin |
[[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C474021 |
indirubin-3'-monoxime |
indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA] | increases expression|increases reaction | 18344322
|
C474021 |
indirubin-3'-monoxime |
indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | increases expression|increases reaction | 18344322
|
C016371 |
lonidamine |
lonidamine inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] | affects transport|decreases reaction|increases reaction | 12606488
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of AQP9 mRNA | increases expression | 17616710
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of AQP9 mRNA | increases expression | 17560707
|
D010693 |
Phloretin |
Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] | affects transport|decreases reaction|increases reaction | 12606488
|
D010693 |
Phloretin |
Phloretin results in decreased activity of AQP9 protein | decreases activity | 12606488
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of AQP9 mRNA | decreases expression | 18445702
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of AQP9 mRNA | increases expression | 19733843
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of AQP9 protein | increases expression | 19733843
|
D013012 |
Sorbitol |
Sorbitol inhibits the reaction [AQP9 protein results in increased uptake of arsenite] | decreases reaction|increases uptake | 19341753
|
D020058 |
Styrene |
Styrene results in increased expression of AQP9 mRNA | increases expression | 17654243
|
C021751 |
tanshinone |
[indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | affects cotreatment|increases expression|increases reaction | 18344322
|
C021751 |
tanshinone |
tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA] | increases expression|increases reaction | 18344322
|
C021751 |
tanshinone |
tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | increases expression|increases reaction | 18344322
|
C021751 |
tanshinone |
[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein | affects cotreatment|increases expression | 18344322
|
C021751 |
tanshinone |
[[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C021751 |
tanshinone |
[[tetraarsenic tetrasulfide co-treated with tanshinone] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA] | increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
indirubin-3'-monoxime promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | affects cotreatment|increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA] | increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
indirubin promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA] | increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of AQP9 protein] | increases expression|increases reaction | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[[tetraarsenic tetrasulfide co-treated with indirubin] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein | affects cotreatment|increases expression | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[[tetraarsenic tetrasulfide co-treated with tanshinone co-treated with indirubin] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
[[tetraarsenic tetrasulfide co-treated with tanshinone] results in increased expression of AQP9 protein] which results in increased uptake of tetraarsenic tetrasulfide | affects cotreatment|increases expression|increases uptake | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
tetraarsenic tetrasulfide results in increased expression of AQP9 mRNA | increases expression | 18344322
|
C534735 |
tetraarsenic tetrasulfide |
tetraarsenic tetrasulfide results in increased expression of AQP9 protein | increases expression | 18344322
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of AQP9 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of AQP9 mRNA | increases expression | 18796159
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of AQP9 mRNA | decreases expression | 19490992
|
D014212 |
Tretinoin |
[Tretinoin co-treated with arsenic trioxide] results in increased expression of AQP9 mRNA | affects cotreatment|increases expression | 19225113
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of AQP9 mRNA | increases expression | 16968895
|
D014212 |
Tretinoin |
[Tretinoin results in increased expression of AQP9 mRNA] which results in increased import of arsenic trioxide | increases expression|increases import | 16968895
|
D014212 |
Tretinoin |
[Tretinoin results in increased expression of AQP9 mRNA] which results in increased susceptibility to arsenic trioxide | increases expression|increases response to substance | 16968895
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of AQP9 protein | increases expression | 16968895
|
C025643 |
vinclozolin |
vinclozolin affects the expression of AQP9 mRNA | affects expression | 19015723
|
D014807 |
Vitamin D |
Vitamin D results in increased expression of AQP9 protein | increases expression | 15336539
|
D014867 |
Water |
AQP9 protein affects the transport of Water | affects transport | 12606488
|
D014867 |
Water |
CFTR protein promotes the reaction [AQP9 protein affects the transport of Water] | affects transport|increases reaction | 12606488
|
D014867 |
Water |
lonidamine inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] | affects transport|decreases reaction|increases reaction | 12606488
|
D014867 |
Water |
Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] | affects transport|decreases reaction|increases reaction | 12606488
|
D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of AQP9 mRNA | affects cotreatment|increases expression | 20370541
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of AQP9 mRNA | affects cotreatment|increases expression | 18313992
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.53 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.23 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.61 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.51 | 9612607 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.82 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.40 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.40 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.40 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.40 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.02 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.02 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
10.02 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
15.39 | 17620307 19052882 19061943 16434500 18056438 17162532 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.39 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.39 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.37 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.57 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.36 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.67 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.39 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.76 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.15 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.54 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.54 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.19 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.24 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.09 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.69 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
19.56 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
19.56 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
19.56 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
19.56 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.56 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.54 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
3.54 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.54 | 16675129 14630087 12948864 18497071 17289903 19861407 17018787 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Styrene |
3.54 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
tanshinone |
3.54 | 19885617 15849732 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.54 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
3.54 | 16166294 16873071 16443354 |
MESH:D001991 |
Bronchitis |
|
Antimony |
5.80 | 8768112 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.26 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.03 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.14 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.46 | 3786805 16192424 18705752 16050911 16097048 15673190 10355542 15721981 16011737 16227642 16124888 15700767 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.55 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.83 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
15.89 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
15.89 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.89 | 11135700 16217749 15073043 15553829 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
15.89 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
15.89 | 21159647 3084413 18506893 19701751 16288022 16935385 19822196 20214788 19519916 18210153 17138121 16569478 20524982 20727157 16779866 18788625 19394651 18393292 17978847 19052882 20007298 16328049 16807293 16502159 20084675 19539802 19171122 19208518 11831363 18056438 19335982 16878318 17761372 18494052 17173139 16681979 3581430 18785209 19107877 20935162 18971187 19919837 20101231 20514400 19383236 17055752 20432363 17162532 16540662 16830150 10737359 20512989 19418558 18978308 18691550 18665156 16698587 17428255 10672840 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.89 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
15.89 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.89 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.54 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.52 | 7296757 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.84 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
6.91 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
6.91 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
6.91 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.19 | 18670907 18850075 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Antimony |
3.81 | 10334427 |
MESH:D002386 |
Cataract |
marker/mechanism |
|
| |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.90 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
18.72 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
18.72 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
18.72 | 2727394 17174075 21159647 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.72 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
18.72 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.26 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.42 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.42 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
17.25 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
17.25 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
17.25 | 15861022 17110522 17681005 11677210 16105132 17333356 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
17.25 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.83 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.30 | 15340226 8697196 15668235 16354765 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.30 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.39 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.53 | 15037631 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.85 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.79 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.88 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.54 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.54 | 8800419 10589399 9211117 17551590 9664655 16925845 14991402 9125849 9224671 9142499 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.03 | 14966744 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.80 | 15213294 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.50 | 18759878 11298694 8156756 8970840 2524372 11906362 12868966 14531868 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.27 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.19 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
3.93 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.93 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.14 | 19279558 |
MESH:D004283 |
Dog Diseases |
|
Antimony |
5.33 | 12019027 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.10 | 16192314 8291058 1440618 6482804 7440962 9022650 11289319 18692083 9328219 18289764 6679447 9653073 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.10 | 7179309 19085960 15998439 16177239 3786805 19336974 6623471 2869522 7120509 7440962 3732212 16227642 6884620 9327722 10092053 4309450 15027814 15968718 10915739 17522070 21278145 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.10 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.10 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
12.49 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
12.49 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
12.49 | 15040536 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
9.80 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
9.80 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
9.80 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.84 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.84 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.88 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.71 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.71 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.74 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.79 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
9.65 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
9.65 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.65 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
9.65 | 15150132 15623463 15878914 15547721 16805852 16704527 15264214 15547733 16510608 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.04 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.04 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
38.26 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
38.26 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
38.26 | 12631006 17595544 15959796 16239168 61145 16045604 19224547 12795759 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
38.26 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
38.26 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
38.26 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
38.26 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
38.26 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.14 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.69 | 6705139 |
MESH:D005355 |
Fibrosis |
|
arsenite |
24.35 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
24.35 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
24.35 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
24.35 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
24.35 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.95 | 16904648 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.61 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.97 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.35 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.89 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.80 | 17312396 |
MESH:D005910 |
Glioma |
|
tanshinone |
3.90 | 16955220 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.74 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.26 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.97 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Styrene |
5.13 | 17420221 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.83 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.08 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.08 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.08 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.34 | 20558911 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.41 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.09 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.05 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
8.20 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.20 | 19110552 19900420 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
4.81 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
4.81 | 15309715 15631357 12044531 16476009 15274664 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
12.62 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.62 | 19176532 18467677 19772884 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.62 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.70 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
6.48 | 20032539 17530837 9296927 11141242 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
6.48 | 11141242 20032539 11363243 17358032 11698656 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.89 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.42 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.71 | 8697196 16354765 15340226 16959395 18606429 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.21 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.21 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.21 | 16899240 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.25 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.90 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.62 | 15034207 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
5.60 | 11275354 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.52 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.52 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.77 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
tanshinone |
4.96 | 19662366 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.49 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.16 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.95 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.95 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
9.95 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.36 | 18785209 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
7.36 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.36 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.49 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.49 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.45 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.69 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.97 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.11 | 15604871 |
MESH:D007674 |
Kidney Diseases |
marker/mechanism |
|
| |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
8.96 | 10903974 8314463 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.96 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.96 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.63 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.63 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
15.63 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
15.63 | 12579204 |
MESH:D007896 |
Leishmaniasis |
|
Antimony |
4.54 | 15220340 10953559 12019027 21182181 21063981 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Antimony |
4.40 | 11475954 8889330 19141829 |
MESH:D007897 |
Leishmaniasis, Mucocutaneous |
|
Antimony |
5.16 | 10651420 10881086 9643325 11370249 7854095 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Antimony |
4.27 | 7554475 7875148 1899875 11105143 20495762 7854095 8142506 |
MESH:D007938 |
Leukemia |
therapeutic |
|
| 15336539 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.79 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.79 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
8.87 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
8.87 | 20370541 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.98 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
8.17 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
tetraarsenic tetrasulfide |
8.17 | 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.51 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.51 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
therapeutic |
|
| 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.95 | 17050201 19850784 16968895 20471514 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.95 | 16294345 19850784 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Vitamin D |
5.95 | 20368581 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.93 | 12712474 15622746 17107899 19075265 9834237 17869043 16112521 16823087 11468182 16891316 19035177 12679006 16330433 17649720 19642359 15213294 17712046 16966277 17217047 19225113 15336539 16331271 15748426 11161223 12018890 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.93 | 17339181 12679006 9834237 16331271 17107899 17506722 17712046 17368321 19035177 16140955 17301526 16766008 16935935 17217047 19642359 15748426 17649720 19225113 17294898 16823087 16788101 17361223 19029980 16891316 19075265 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.04 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
11.85 | 8812269 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
11.85 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.08 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
10.04 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.04 | 16239168 16943688 16221502 11408273 17157831 17174718 17334410 21278145 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.04 | 18522880 19638242 20032147 18407596 18665156 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.99 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.24 | 18395914 18251166 17766677 18376398 12958196 17714472 20821823 18472332 15996030 18054572 15876570 15818738 15673190 17761835 16192424 14748882 15893842 14716496 17525996 12666154 12632514 17823541 18210741 12445418 17640975 18277467 12632512 17708605 18418968 16015684 18412020 15925388 15362042 17698563 13678700 18317297 12586293 15057751 12741479 18481824 11481614 18166357 18187930 18263696 17721639 17976157 15650968 16116963 10355542 18006644 18205269 16011737 12667390 17565644 15338365 14716833 18156304 17944888 17805973 18472094 16027843 18395095 18279442 14512876 12546737 17481882 14724832 15931870 18339082 12389079 18429990 15959796 15123356 16033810 17557913 18705752 12445421 17922224 15730626 12649538 12898905 18420326 16248980 14620537 17631135 15052691 16638106 17900296 16136751 17869086 16097048 15370692 12609069 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.24 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.24 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.24 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.24 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.77 | 15720792 16964402 15830285 16246199 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.77 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.85 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.41 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
27.60 | 15890375 18177683 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
27.60 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
27.60 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
27.60 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
27.60 | 18978307 15175105 21167192 19294768 2862719 18644402 20118626 18977376 20434301 19426721 19255062 18754104 15885732 19690152 19090486 18648771 2422723 20101389 19850985 19254457 19833225 19427195 20583210 20452335 21071580 20137499 19256749 19638242 20501860 19499222 19996281 20405173 19642983 12112319 19551842 16942905 9163691 20492335 12771043 21278145 10737359 19073162 19812893 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
27.60 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
27.60 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
27.60 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
27.60 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
20.72 | 6587162 598648 1399818 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
20.72 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
20.72 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
20.72 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
20.72 | 18775883 9362446 17942915 19539802 18079962 21159647 18164116 18282651 19126423 19009564 3124819 18308698 18544905 19004024 18253720 2563599 16267830 19519916 16842330 18093689 17854601 17174075 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
20.72 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.11 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.96 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.52 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
14.52 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
14.52 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.52 | 18816296 17053015 6695378 20869020 18569708 20064080 20135361 18520028 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
14.52 | 21163286 20512841 20970405 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.52 | 15276417 17306315 19931552 17077188 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Styrene |
14.52 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.52 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
14.52 | 18800350 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Styrene |
5.13 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.36 | 16891317 11807958 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.15 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.65 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.14 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.14 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.11 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.46 | 16801185 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.51 | 17358032 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.94 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.88 | 14977855 11468182 15949261 19549372 19417148 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.19 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.34 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
marker/mechanism |
|
| 18575777 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.77 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.77 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.01 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.76 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.43 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.43 | 16411023 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.65 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.25 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.25 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
10.48 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.48 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.48 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
10.48 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.35 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.07 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.07 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.11 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.01 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.54 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.54 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.54 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
15.58 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
15.58 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
15.58 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
15.58 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.08 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.79 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.63 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.73 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.14 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.69 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Vitamin D |
4.52 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
10.38 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.38 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.38 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
10.38 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.65 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
7.90 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
7.90 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.90 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.39 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.17 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.86 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.92 | 12520081 |
MESH:D010409 |
Penile Diseases |
|
Antimony |
5.41 | 9643325 |
MESH:D010493 |
Pericarditis |
|
Antimony |
5.79 | 20465667 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.14 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.25 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.04 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.04 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
14.42 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.42 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
14.42 | 18042343 19015723 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.61 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.59 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.12 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.12 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.12 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.61 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.31 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.99 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.11 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.47 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.23 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.53 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.14 | 3692021 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.21 | 9296927 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.80 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.65 | 16646077 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.25 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
12.25 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.25 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.25 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.61 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.55 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
7.82 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
7.82 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
7.82 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
7.82 | 12958204 17575124 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.82 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
7.82 | 17696246 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.32 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.88 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.57 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.08 | 1399818 3712494 7505956 6582329 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
15.08 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
15.08 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
15.08 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.35 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.51 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.64 | 15213294 |
MESH:D014352 |
Trypanosomiasis |
|
Antimony |
5.60 | 15220340 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.03 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.82 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
10.82 | 12973940 20435036 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
10.82 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
10.82 | 16452187 16712894 11723127 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.48 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.48 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.99 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.28 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.65 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.44 | 12579204 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.10 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.26 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.75 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.92 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.69 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.11 | 17120751 |